Memphis Pharmaceuticals & Chemical Industries reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was EGP 302.65 million compared to EGP 257.23 million a year ago. Net income was EGP 27.56 million compared to EGP 9.58 million a year ago.